Literature DB >> 18202697

New approaches for imaging tumour responses to treatment.

Kevin Brindle1.   

Abstract

Tumour responses to treatment are still largely assessed from imaging measurements of reductions in tumour size. However, this can take several weeks to become manifest and in some cases may not occur at all, despite a positive response to treatment. There has been considerable interest, therefore, in non-invasive techniques for imaging tissue function that can give early evidence of response. These can be used in clinical trials of new drugs to give an early indication of drug efficacy, and subsequently in the clinic to select the most effective therapy at an early stage of treatment.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18202697     DOI: 10.1038/nrc2289

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  135 in total

Review 1.  Stable isotope-resolved metabolomics and applications for drug development.

Authors:  Teresa W-M Fan; Pawel K Lorkiewicz; Katherine Sellers; Hunter N B Moseley; Richard M Higashi; Andrew N Lane
Journal:  Pharmacol Ther       Date:  2011-12-23       Impact factor: 12.310

Review 2.  Imaging radiation response in tumor and normal tissue.

Authors:  Marjan Rafat; Rehan Ali; Edward E Graves
Journal:  Am J Nucl Med Mol Imaging       Date:  2015-06-15

Review 3.  Computerized PET/CT image analysis in the evaluation of tumour response to therapy.

Authors:  W Lu; J Wang; H H Zhang
Journal:  Br J Radiol       Date:  2015-02-27       Impact factor: 3.039

4.  In vivo targeting of cell death using a synthetic fluorescent molecular probe.

Authors:  Bryan A Smith; Shuzhang Xiao; William Wolter; James Wheeler; Mark A Suckow; Bradley D Smith
Journal:  Apoptosis       Date:  2011-07       Impact factor: 4.677

Review 5.  The role of radionuclide probes for monitoring anti-tumor drugs efficacy: A brief review.

Authors:  Renata Salgado Fernandes; Carolina de Aguiar Ferreira; Daniel Cristian Ferreira Soares; Anna Margherita Maffione; Danyelle M Townsend; Domenico Rubello; André Luís Branco de Barros
Journal:  Biomed Pharmacother       Date:  2017-09-12       Impact factor: 6.529

6.  Monitoring chemotherapeutic response by hyperpolarized 13C-fumarate MRS and diffusion MRI.

Authors:  Lionel Mignion; Prasanta Dutta; Gary V Martinez; Parastou Foroutan; Robert J Gillies; Bénédicte F Jordan
Journal:  Cancer Res       Date:  2013-11-27       Impact factor: 12.701

7.  Metabolic response of glioma to dichloroacetate measured in vivo by hyperpolarized (13)C magnetic resonance spectroscopic imaging.

Authors:  Jae Mo Park; Lawrence D Recht; Sonal Josan; Milton Merchant; Taichang Jang; Yi-Fen Yen; Ralph E Hurd; Daniel M Spielman; Dirk Mayer
Journal:  Neuro Oncol       Date:  2013-01-17       Impact factor: 12.300

8.  Optical imaging of mammary and prostate tumors in living animals using a synthetic near infrared zinc(II)-dipicolylamine probe for anionic cell surfaces.

Authors:  Bryan A Smith; Walter J Akers; W Matthew Leevy; Andrew J Lampkins; Shuzhang Xiao; William Wolter; Mark A Suckow; Samuel Achilefu; Bradley D Smith
Journal:  J Am Chem Soc       Date:  2010-01-13       Impact factor: 15.419

9.  Production of hyperpolarized [1,4-13C2]malate from [1,4-13C2]fumarate is a marker of cell necrosis and treatment response in tumors.

Authors:  Ferdia A Gallagher; Mikko I Kettunen; De-En Hu; Pernille R Jensen; René In 't Zandt; Magnus Karlsson; Anna Gisselsson; Sarah K Nelson; Timothy H Witney; Sarah E Bohndiek; Georg Hansson; Torben Peitersen; Mathilde H Lerche; Kevin M Brindle
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-10       Impact factor: 11.205

Review 10.  Imaging in the era of molecular oncology.

Authors:  Ralph Weissleder; Mikael J Pittet
Journal:  Nature       Date:  2008-04-03       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.